Projects

ICMR - ICRAG 2 - Cross sectional study

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2024 - Ongoing

Project Lead

Dr. Farah Naaz Fathima, Dr. Soumya Umesh

Authors

Dr. Farah Naaz Fathima, Dr. Soumya Umesh, Dr. Thenmozhi N, Dr. Jonita Evett Fernandez, Dr. Pooja R Sridhar

Project Status

ongoing

Project Type

ICMR study